Aug 04, 2022
Pharming Group reports financial results for the first half of 2022
Pharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022. The Company held an analyst conference call on August 4, 2022 at 13.30 CET/07.30 EST.  To launch the audio webcast recording of the call please click on  this link . 
Jul 25, 2022
Pharming Group Notice of H1 2022 Results
Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will announce financial results for the six months ended 30 June 2022 on Thursday, August 4, 2022. The Company will host a presentation for analysts at 13:30 CET/07:30 EST on August 4, 2022.
Jun 02, 2022
Pharming Group to present at Jefferies Healthcare Conference 2022
Pharming announces that its Chief Executive Officer, Sijmen de Vries, will present at the Jefferies Healthcare Conference 2022, a hybrid meeting based in New York, at 22:00-22:30 CET/16:00-16:30 EDT on 9 June 2022. The Jefferies Healthcare Conference is a gathering of over 400 public and private
May 18, 2022
Pharming Group: all proposals Annual General Meeting of Shareholders approved
Pharming Group N.V. announces that at its Annual General Meeting of shareholders (AGM), held today, all proposals were approved. The shareholders adopted the financial statements for the 2021 financial year (agenda item 2.e); approved the proposal to grant discharge to the members of the Board of
May 05, 2022
Pharming Group Notice of Q1 2022 Results
Pharming confirms it will announce financial results for the first quarter of the year ended 31 March 2022 on Thursday, 12 May 2022. The Company will host a presentation for analysts at 13:30 CET/07:30 EST on 12 May 2022. Details for the presentation can be found below.  Conference call dial-in
Displaying 1 - 10 of 12